CSL, AU000000CSL8

CSL defends shareholder class action. CSL stock is valued at AUD 94.1 billion

Published on 10/22/2026 at 11:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The proceeding covers guidance from February 11, 2025 to May 11, 2026. CSL stock costs EUR 121.30 on October 22, 2026 before the October 27 AGM.

CSL faces legal scrutiny

  • A shareholder proceeding filed on October 22, 2026 concerns CSL guidance issued between February 11, 2025 and May 11, 2026.
  • Fiscal year 2026 revenue was USD 15.8 billion, down 1 percent, while underlying NPATA fell 2 percent to USD 3.1 billion.
  • CSL stock trades at EUR 121.30 at 11:30 a.m. CEST at Lang & Schwarz on October 22, 2026.
  • CSL's annual general meeting is scheduled for October 27, 2026.
CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL (ISIN AU000000CSL8) was trading at EUR 121.30 at Lang & Schwarz on October 22, 2026 at 11:30 a.m. CEST as the company faced a shareholder class action over earlier guidance. The proceeding concerns securities acquired between February 11, 2025 and May 11, 2026, according to Business News Australia.

What does the proceeding cover?

Business News Australia reported on October 22, 2026 that CSL had been notified of a group proceeding filed in the Supreme Court of Victoria. The allegations relate to medium-term performance statements, fiscal year 2026 revenue guidance and net profit guidance, while CSL denies liability and intends to defend the case.

The financial backdrop is material. CSL's fiscal year 2026 revenue was USD 15.8 billion, down 1 percent, while underlying NPATA declined 2 percent to USD 3.1 billion, according to the company's earnings-call transcript carried by Yahoo Finance. Statutory NPAT was a loss of USD 2.6 billion after restructuring and impairment charges.

Three dates frame the reset

On October 28, 2025, CSL said medium-term earnings growth would be high single digit rather than double digit, according to Business News Australia. On May 11, 2026, it cut fiscal year 2026 guidance to USD 15.2 billion of revenue and USD 3.1 billion of NPATA. On October 21, 2026, CSL appointed Deborah Waterhouse as chief executive and managing director from February 1, 2027, according to CSL.

Which dates come next?

CSL's 2026 annual general meeting is scheduled for October 27, 2026, according to the company's investor-relations page. Waterhouse is scheduled to begin as CEO on February 1, 2027, while interim CEO Gordon Naylor is due to return to the board after the transition.

Stock valuation remains a market measure

CSL's ASX quote was last at AUD 196.14 on October 22, 2026 at 4:18 p.m. AEDT, with a market capitalization of AUD 94.1 billion and a 52-week range of AUD 90.00 to AUD 275.79. The current legal issue therefore sits alongside a leadership transition and a reported earnings reset, giving investors three dated reference points for the stock's next phase.

Price and legal context

The euro quote was trading at EUR 121.30 at Lang & Schwarz on October 22, 2026 at 11:30 a.m. CEST. The next scheduled company date is the October 27, 2026 annual general meeting.

The further course of trading is shown by the continuously updated real-time quote of CSL stock.

CSL stock facts

  • Company: CSL Limited
  • ISIN: AU000000CSL8
  • Ticker: CSL
  • Primary exchange: ASX
  • Price Lang & Schwarz (as of October 22, 2026, 11:30 a.m. CEST): EUR 121.30
  • Market capitalization: AUD 94.1 billion (as of October 22, 2026)
  • 52-week range: AUD 90.00-275.79 (as of October 22, 2026)
  • Sector / Industry: Healthcare / Biotechnology

Market context: Market report S&P/ASX 200.

More news and analyses on CSL stock

Disclaimer...
en | AU000000CSL8 | CSL | boerse | 70392794 | bgmi